Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The SPRAINED Study is a multi-centre observational cohort study of acute ankle sprains that present to NHS Emergency Departments. The study is validating a prognostic tool for use in Emergency Departments for patients with acute ankle sprain to identify those in whom recovery may be substantially prolonged or incomplete and additional investigations or treatment is indicated. The study was funded by the NIHR HTA (project number 13/19/06) and opened to recruitment in July 2015 to March 2016.

Recruitment was initially slow as the 10 participating sites progressively opened in the summer months of 2015. However, recruitment accelerated rapidly through autumn 2015 with all sites active and the momentum was maintained to slightly exceed our target of 675 with 682 participants recruited. The study is now in follow-up with patient reported outcomes being collected throughout 2016 at 4 weeks, 4 months, and 9 months following the patient’s ankle sprain. The final results will be available in 2017. 

Similar stories

SCIENCE spreads across the world

Oxford Trauma are pleased to open their first overseas site for the SCIENCE study.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

PRoCuRe opens to recruitment

The Partial Rotator Cuff Tear Repair Trial (PRoCuRe) is open to recruitment at Oxford University Hospitals NHS Foundation Trust after achieving OCTRU Green Light approval!

IMP-MEL Trial given Green Light to open

OCTRU have now given Green Light approval for IMP MEL to open. This is a phase 1 first-in-human dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC.

WISE opens to recruitment

The WISE Study - Wrist Injury Strengthening Exercise: a randomised multicentre feasibility study of resistance exercise versus usual care for optimising function after distal radius fracture in adults aged 50 years or over has now received OCTRU Green Light approval and has opened to recruitment.